Diprivan is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Propofol.
| Product ID | 63323-269_1b4df97b-78a7-4fff-aaa2-ea122a6b5079 |
| NDC | 63323-269 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Diprivan |
| Generic Name | Propofol |
| Dosage Form | Injection, Emulsion |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2009-11-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019627 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | PROPOFOL |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2009-11-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-17 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-17 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-17 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-17 |
| Marketing End Date | 2013-08-07 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Marketing End Date | 2014-02-28 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-11-13 |
| Ingredient | Strength |
|---|---|
| PROPOFOL | 10 mg/mL |
| SPL SET ID: | d1ae9e26-ffd6-43df-bbd6-869cdede6afe |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52584-269 | Diprivan | Diprivan |
| 63323-269 | Diprivan | Diprivan |
| 65219-800 | Diprivan | Diprivan |
| 18124-027 | Fresenius Propoven 2% | PROPOFOL |
| 0069-0209 | Propofol | Propofol |
| 0069-0234 | Propofol | Propofol |
| 0069-0248 | Propofol | Propofol |
| 0404-9943 | PROPOFOL | propofol |
| 0409-4699 | PROPOFOL | PROPOFOL |
| 0409-6010 | PROPOFOL | PROPOFOL |
| 0591-2136 | Propofol | Propofol |
| 0641-6194 | Propofol | Propofol |
| 0641-6195 | Propofol | Propofol |
| 0641-6196 | Propofol | Propofol |
| 16714-528 | propofol | propofol |
| 16714-690 | propofol | propofol |
| 16714-977 | propofol | propofol |
| 23155-345 | propofol | propofol |
| 25021-608 | propofol | propofol |
| 50090-4569 | Propofol | Propofol |
| 51662-1293 | PROPOFOL | PROPOFOL |
| 51662-1470 | PROPOFOL | PROPOFOL |
| 51662-1471 | PROPOFOL | PROPOFOL |
| 52584-054 | Propofol | Propofol |
| 52584-098 | PROPOFOL | propofol |
| 52584-699 | Propofol | Propofol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DIPRIVAN 73441920 1304645 Live/Registered |
Imperial Chemical Industries PLC 1983-09-01 |